Applied Genetic Technologies Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AGTC research report →
About the company
Applied Genetic Technologies Corporation (AGTC) is a clinical-stage biotechnology company focused on developing innovative genetic therapies aimed at transforming the lives of patients battling rare and debilitating diseases. Its advanced product portfolio includes three ophthalmology development programs addressing two specific targets. These encompass treatments for X-linked retinitis pigmentosa and achromatopsia, both currently undergoing Phase 1/2 clinical trials.
- CEO
- Susan Washer
- IPO
- 2014
- Employees
- 102
- HQ
- Alachua, FL, US
Price Chart
- Market Cap
- $0
- P/E
- -0.25
- P/S
- 0.00
- P/B
- 0.60
- EV/EBITDA
- 0.37
- Div Yield
- 0.00%
- Gross Margin
- 100.00%
- Op Margin
- -20390.46%
- Net Margin
- -21976.62%
- ROE
- -123.91%
- ROIC
- -127.33%
- Revenue
- $325.00K · -35.00%
- Net Income
- $-71,424,000 · -23.51%
- EPS
- $-1.59 · 10.17%
- Op Income
- $-66,269,000
- FCF YoY
- -27.77%
- 52W High
- $2.83
- 52W Low
- $0.23
- 50D MA
- $0.35
- 200D MA
- $0.67
- Beta
- 1.58
- Avg Volume
- 1.32M
Get TickerSpark's AI analysis on AGTC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 30, 22 | Robinson James A. Jr. | sell | 25,000 |
| Nov 30, 22 | VANLENT ANNE | sell | 14,000 |
| Nov 30, 22 | Rosen James | other | 1,000 |
| Nov 30, 22 | Rosen James | sell | 14,000 |
| Nov 30, 22 | Aliski William | other | 8,500 |
| Nov 30, 22 | Aliski William | sell | 14,000 |
| Nov 30, 22 | HURWITZ EDWARD | other | 1,800 |
| Nov 30, 22 | HURWITZ EDWARD | sell | 14,000 |
| Nov 30, 22 | Hashad Yehia | sell | 14,000 |
| Nov 30, 22 | Koenig Scott | sell | 14,000 |
Our AGTC coverage
Recent articles, reports, and earnings notes.
No research on AGTC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AGTC report →Similar companies
Peers in the same neighborhood.